Cita APA

Risco-Risco, C., Henriquez-Camacho, C., Herrera-Rueda, M., Barberán, J., & Andaluz-Ojeda, D. (2024). Cefiderocol Versus Best Available Therapy in the Treatment of Critically Ill Patients with Severe Infections Due to Resistant Gram-Negative Bacteria: A Systematic Review and Meta-Analysis.

Citación estilo Chicago

Risco-Risco, Carlos, César Henriquez-Camacho, Marta Herrera-Rueda, José Barberán, y David Andaluz-Ojeda. Cefiderocol Versus Best Available Therapy in the Treatment of Critically Ill Patients With Severe Infections Due to Resistant Gram-Negative Bacteria: A Systematic Review and Meta-Analysis. 2024.

Cita MLA

Risco-Risco, Carlos, et al. Cefiderocol Versus Best Available Therapy in the Treatment of Critically Ill Patients With Severe Infections Due to Resistant Gram-Negative Bacteria: A Systematic Review and Meta-Analysis. 2024.